BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23160480)

  • 1. Severe growth deficiency is associated with STAT5b mutations that disrupt protein folding and activity.
    Varco-Merth B; Feigerlová E; Shinde U; Rosenfeld RG; Hwa V; Rotwein P
    Mol Endocrinol; 2013 Jan; 27(1):150-61. PubMed ID: 23160480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant folding of a mutant Stat5b causes growth hormone insensitivity and proteasomal dysfunction.
    Chia DJ; Subbian E; Buck TM; Hwa V; Rosenfeld RG; Skach WR; Shinde U; Rotwein P
    J Biol Chem; 2006 Mar; 281(10):6552-8. PubMed ID: 16303763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutant signal transducer and activator of transcription 5b, associated with growth hormone insensitivity and insulin-like growth factor-I deficiency, cannot function as a signal transducer or transcription factor.
    Fang P; Kofoed EM; Little BM; Wang X; Ross RJ; Frank SJ; Hwa V; Rosenfeld RG
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1526-34. PubMed ID: 16464942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel missense mutation in the SH2 domain of the STAT5B gene results in a transcriptionally inactive STAT5b associated with severe IGF-I deficiency, immune dysfunction, and lack of pulmonary disease.
    Scaglia PA; Martínez AS; Feigerlová E; Bezrodnik L; Gaillard MI; Di Giovanni D; Ballerini MG; Jasper HG; Heinrich JJ; Fang P; Domené HM; Rosenfeld RG; Hwa V
    J Clin Endocrinol Metab; 2012 May; 97(5):E830-9. PubMed ID: 22419735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of STAT proteins on growth hormone-mediated IGF-I gene expression.
    Varco-Merth B; Rotwein P
    Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E847-55. PubMed ID: 25205818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta.
    Rui L; Gunter DR; Herrington J; Carter-Su C
    Mol Cell Biol; 2000 May; 20(9):3168-77. PubMed ID: 10757801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.
    Nieborowska-Skorska M; Wasik MA; Slupianek A; Salomoni P; Kitamura T; Calabretta B; Skorski T
    J Exp Med; 1999 Apr; 189(8):1229-42. PubMed ID: 10209040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
    Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
    Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.
    Park SH; Yamashita H; Rui H; Waxman DJ
    Mol Endocrinol; 2001 Dec; 15(12):2157-71. PubMed ID: 11731617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signalling cross-talk between hepatocyte nuclear factor 4alpha and growth-hormone-activated STAT5b.
    Park SH; Wiwi CA; Waxman DJ
    Biochem J; 2006 Jul; 397(1):159-68. PubMed ID: 16584384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical characterization of diverse Stat5b-binding enhancers that mediate growth hormone-activated insulin-like growth factor-I gene transcription.
    Varco-Merth B; Mirza K; Alzhanov DT; Chia DJ; Rotwein P
    PLoS One; 2012; 7(11):e50278. PubMed ID: 23185594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel multiplexed assay for identifying SH2 domain antagonists of STAT family proteins.
    Takakuma K; Ogo N; Uehara Y; Takahashi S; Miyoshi N; Asai A
    PLoS One; 2013; 8(8):e71646. PubMed ID: 23977103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the cytokine-induced SH2 domain-containing protein CIS in growth hormone receptor internalization.
    Landsman T; Waxman DJ
    J Biol Chem; 2005 Nov; 280(45):37471-80. PubMed ID: 16154995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation.
    Vidarsdottir S; Walenkamp MJ; Pereira AM; Karperien M; van Doorn J; van Duyvenvoorde HA; White S; Breuning MH; Roelfsema F; Kruithof MF; van Dissel J; Janssen R; Wit JM; Romijn JA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3482-5. PubMed ID: 16787985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPARalpha) signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity mediated by stat5b.
    Zhou YC; Waxman DJ
    J Biol Chem; 1999 Jan; 274(5):2672-81. PubMed ID: 9915797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase.
    Ram PA; Waxman DJ
    J Biol Chem; 1997 Jul; 272(28):17694-702. PubMed ID: 9211920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current issues on molecular diagnosis of GH signaling defects.
    Feigerlova E; Hwa V; Derr MA; Rosenfeld RG
    Endocr Dev; 2013; 24():118-27. PubMed ID: 23392100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
    Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
    Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel Y332C missense mutation in the intracellular domain of the human growth hormone receptor does not alter STAT5b signaling: redundancy of GHR intracellular tyrosines involved in STAT5b signaling.
    Derr MA; Fang P; Sinha SK; Ten S; Hwa V; Rosenfeld RG
    Horm Res Paediatr; 2011; 75(3):187-99. PubMed ID: 20962506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular interactions of EphA4, growth hormone receptor, Janus kinase 2, and signal transducer and activator of transcription 5B.
    Sawada T; Arai D; Jing X; Miyajima M; Frank SJ; Sakaguchi K
    PLoS One; 2017; 12(7):e0180785. PubMed ID: 28686668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.